Socialist Party deputy Juan Luis Castro has revealed his growing suspicions regarding possible price-fixing between several laboratories across the country, representing much of Chile’s pharmaceutical industry. The congressman has pointed to a 42% increase in the prices of 16 of the country’s 20 most-used medications, all during a short period between 2015 and 2016.
Castro, who is a member of the Health Commission, believes that “this increase in the price of 20 of Chile’s most consumed medications is a low blow to the middle class and all popular sectors, since it implies increases in common remedies such as paracetamol, ibuprofen, loratadine, salbutamol and many other daily-use substances.”
Castro announced his intentions to “take these findings to the Public Health Institute and the National Economic Prosecutor, because there probably are signs of collusion, agreements to raise prices in their products, as has already been seen with drugstores and which may now be occurring between laboratories.”
Full Content: Terra
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Government Approves Vodafone-Hutchison Merger
May 9, 2024 by
CPI
Senate Majority Leader Announces Plan for AI Regulation Framework
May 9, 2024 by
CPI
BBVA Initiates Aggressive Takeover Bid for Sabadell
May 9, 2024 by
CPI
TikTok to Label AI-Generated Content Amid Election Interference Concerns
May 9, 2024 by
CPI
Italy’s Antitrust Authority Imposes Heavy Fines on Car Rental Giants
May 9, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI